UT Health San Antonio School of Medicine


 

IDF Congress 2022: Efficacy and Safety of Finerenone by Age and Sex Subgroups in Patients with CKD and T2D

487 views
January 30, 2023
0 Comments
Login to view comments. Click here to Login